Saxagliptin CAS 361442-04-8 Saxagliptin 15ND2 Diabetes API
Saxagliptin |
CAS No.: 361442-04-8 |
Purity:≥98% |
Molecular weight: 315.41 g/mol |
Molecular formula: C₁₈H₂₅N₃O₂ |
Appearance:White to white crystalline powder |
Package: 1g,10g,100g,1000g |
Saxagliptin CAS 361442-04-8 Saxagliptin 15ND2 Diabetes API
Color:white to off-white
Form:Solid
Stability:temperature Sensitive
Melting point:103-107℃
Leave a Message
We will call you back soon!
Dear,
I am interested in Saxagliptin CAS 361442-04-8 Saxagliptin 15ND2 Diabetes API, could you send me more details such as type, size, MOQ, material, etc.
Thanks!
Waiting for your reply.
Highlight: Saxagliptin Active Pharmaceutical Ingredient,361442-04-8 Active Pharmaceutical Ingredient,15ND2 saxagliptin
Saxagliptin CAS 361442-04-8 Saxagliptin 15ND2 Diabetes API
Description
Saxagliptin is an oral hypoglycemic drug of the dipeptidyl peptidase-4(DPP-4) inhibitor class, which sold under the brand name Obglyza. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug.
Basic parameters
Drug class | DPP-4 inhibitors |
Density | 1.35 |
Storage temp. | 2-8℃ |
Synonym | Saxagliptin 15ND2 |
Solubility | DMSO (Slightly), Methanol (Sparingly) |
HS Code | 29339900 |
Chemical Formula
What is the function of Saxagliptin?
It is a type 2 diabetes drug that can stimulate the pancreas to produce more insulin after the meal. Also it is a reversible, competitive dipeptidyl peptidase-4 inhibitor. Saxagliptin acts by preventing the degradation of glucagon-like peptide-1 and hence increases secretion of insulin and decreases secretion of glucagon.
Reference
https://www.ncbi.nlm.nih.gov>pmc
Recommended Products